Embecta (NASDAQ: EMBC.V)
$10.31
(-0.9%)
-$0.09
Price as of April 26, 2024, 4:00 p.m. ET
Embecta Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Embecta Company Info
Embecta Corp. engages in manufacturing and distributing medical devices used in the treatment of diabetes. It delivers insulin for diabetic patients to improve their lives. The company is headquartered in Parsippany, NJ.
News & Analysis
Featured Article
Why Embecta Stock Is Tanking Today
There was good news and bad news with the diabetes care company's fiscal Q1 update.
Keith Speights | Feb 9, 2024
Featured Article
3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential
These three spinoffs are already profitable.
Jim Halley | Mar 26, 2023
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.